SCHEMBL2017604

SCHEMBL2017604

CS(=O)(=O)c1n[nH]c2cc[c]cc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 3/20 0.33
▸ LRRK2 Q5S007 1/20 0.32
▸ PRKD3 O94806 2/20 0.32
▸ ROCK1 Q13464 2/20 0.32
▸ CLK4 Q9HAZ1 2/20 0.32
▸ JAK2 O60674 2/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ CDK8 P49336 1/20 0.32
▸ LIMK1 P53667 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ CDC7 O00311 1/20 0.32
▸ PLK4 O00444 1/20 0.32
▸ DAPK3 O43293 1/20 0.32
▸ DYRK3 O43781 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ ROS1 P08922 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ MARK3 P27448 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10608557 0.75 CYP1A2 (0.50) CSNK2A1LRRK2JAK2CHEK1CDK2
SCHEMBL1694765 0.73 CYP1A2 (0.43) JAK2CYP1A2
SCHEMBL478887 0.72 PDPK1 (0.54) JAK2TYK2JAK3
SCHEMBL2563702 0.70 NTRK1 (0.34) LRRK2
SCHEMBL16097619 0.70 KDM4E (0.31) CYP1A2
SCHEMBL8820458 0.70 JAK2 (0.54) CSNK2A1LRRK2PRKD3ROCK1CLK4
SCHEMBL2016414 0.70 KDM4E (0.41) CSNK2A1CDK2
SCHEMBL2305274 0.69 KDM4E (0.32) JAK2
SCHEMBL18188335 0.69 KDM4E (0.32) —
SCHEMBL5662185 0.69 PDPK1 (0.36) CSNK2A1PRKD3CLK4JAK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516438-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2012-10-31 — — EP claimed
WO-2011079133-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-06-30 — — WO claimed
EP-2516438-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2012-10-31 — — EP disclosed
WO-2011079133-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-06-30 — — WO disclosed
Send feedback